Internal Medicine, Gastroenterology · Philadelphia, PA
NPI
1457334369
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
525 Jamestown St, Suite 101
Philadelphia, PA, 19128
Phone (215) 463-1483
Groups this clinician bills Medicare through
Medicare paid, 2024
$149K
1,231 services
Medicare patients, 2024
627
Average age 73
Drug cost, 2024
$1.1M
4,306 prescriptions
Company payments, 2025
$33K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Beth C Gardner was code 99214 (office e&m - established), 542 times for 332 patients. In total Beth C Gardner billed 1,231 services in 18 codes, and Medicare paid $149K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 542 | 332 | $95.87 | $52K |
| 99213 Office E&M - Established | Office | 151 | 139 | $60.95 | $9,204 |
| 43239 Upper GI Endoscopy | Facility | 90 | 90 | $75.10 | $6,759 |
| 45380 Lower GI Endoscopy - Other | Facility | 80 | 80 | $134.85 | $11K |
| 99203 Office E&M - New | Office | 67 | 67 | $80.66 | $5,404 |
| 99204 Office E&M - New | Office | 50 | 50 | $127.88 | $6,394 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 47 | 47 | $189.25 | $8,895 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 35 | 35 | $185.52 | $6,493 |
| 43239 Upper GI Endoscopy | Office | 30 | 30 | $276.02 | $8,281 |
| 45385 Colonoscopy - Lesion Removal | Facility | 29 | 29 | $219.30 | $6,360 |
| 45380 Lower GI Endoscopy - Other | Office | 25 | 25 | $359.45 | $8,986 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 22 | 22 | $321.88 | $7,081 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 19 | 19 | $311.22 | $5,913 |
| 45378 Lower GI Endoscopy - Other | Facility | 11 | 11 | $144.13 | $1,585 |
By year: 2022 $162K for 1,144 services; 2023 $167K for 1,204 services; 2024 $149K for 1,231 services.
Medicare prescription drug claims, 2024
In 2024, the drug Beth C Gardner prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,005 prescriptions and refills. In total Beth C Gardner wrote 4,306 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,005 | 2,565 | 295 | $14K |
| Famotidine Generic | 832 | 1,984 | 239 | $10K |
| Dicyclomine Hcl Generic | 423 | 787 | 158 | $9,381 |
| Colestipol Hcl Generic | 276 | 565 | 94 | $15K |
| Omeprazole Generic | 225 | 588 | 67 | $2,896 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 199 | 199 | 199 | $13K |
| Linzess Linaclotide | 192 | 300 | 52 | $164K |
| Esomeprazole Magnesium Generic | 102 | 272 | 32 | $7,952 |
| Mesalamine Generic | 88 | 168 | 23 | $31K |
| Ondansetron Hcl Generic | 77 | 88 | 26 | $444 |
| Metoclopramide Hcl Generic | 75 | 135 | 33 | $429 |
| Prednisone Generic | 57 | 78 | 11 | $451 |
| Sucralfate Generic | 55 | 101 | 25 | $2,449 |
| Zenpep Lipase/Protease/Amylase | 54 | 107 | 16 | $230K |
| Dexlansoprazole Dr Dexlansoprazole | 40 | 96 | 11 | $22K |
Brand drugs: - claims; generic drugs: 3,690 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Beth C Gardner $33K ($33K in general payments such as food, travel and fees) from 17 companies. The largest payer was Aimmune Therapeutics, Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 40 | $15K |
| Olympus America Inc. | 2 | $9,728 |
| Abbvie Inc. ABBV | 57 | $5,607 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 35 | $409 |
| Ardelyx, Inc. ARDX | 17 | $348 |
| Gilead Sciences, Inc. GILD | 12 | $244 |
| Phathom Pharmaceuticals, Inc. PHAT | 19 | $236 |
| QOL Medical, LLC | 15 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $206 |
| Madrigal Pharmaceuticals MDGL | 10 | $158 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.